Month: September 2019
According to BIOLIFE4D, “We have developed a proprietary bioink using a very specific composition of different extracellular matrix compounds that closely replicate the properties of the mammalian heart. Further, it has developed a novel and unique bioprinting algorithm, consisting of printing parameters optimized for the whole heart. Coupling its proprietary bioink with patient-derived cardiomyocytes and its enabling bioprinting technology, BIOLIFE4D is able to bioprint a heart that, while smaller in size, replicates many of the features of a human heart. With this platform technology in place, BIOLIFE4D is now well-positioned to build upon this platform and work towards the development of a full-scale human heart.”
According to Ken Jin, co-founder, and chief technology officer of Meditool, “Meditool is one of the pioneers in developing 3D printed PEEK medical implants. Evonik has been our trusted partner in materials supply. The venture investment will be an extra boost to our endeavor to bring innovative solutions to patients and surgeons in China and the rest of the world.”
Evonik’s venture capital arm has already invested in two funds in China and with Meditool, it now has its first direct investment. Co-investors in Meditool include ZN Ventures, Morningside Ventures, and Puhua Capital.
According to the Wyss Institute for Biologically Inspired Engineering at Harvard University, John A. Paulson School of Engineering and Applied Sciences (SEAS) and co-first author Mark Skylar-Scott, Ph.D., a Research Associate at the Wyss Institute, “This is an entirely new paradigm for tissue fabrication. Rather than trying to 3D-print an entire organ’s worth of cells, SWIFT (sacrificial writing into functional tissue) )focuses on only printing the vessels necessary to support a living tissue construct that contains large quantities of OBBs, which may ultimately be used therapeutically to repair and replace human organs with lab-grown versions containing patients’ own cells.”
According to Hilmar Koerner, Ph.D., research team lead for polymer matrix composite materials and processes at the AFRL Materials and Manufacturing Directorate, “Additive manufacturing is important to the future of aerospace for a variety of reasons. Benefits include complexity enabled capability; low-volume, low-cost manufacturing; part reduction; improved form-fit function; tool-less part manufacturing; and lightweighting of interior hardware, such as air ducts, seat framework and wall panels.”
According to Jeffery Baur, Ph.D., leader of the AFRL Composite Performance Research Team, “Printing composites can produce parts with complex shapes and eliminates the need for the expensive pressure cooker and long heating cycles. The possibility to produce parts in the field or at a depot without a long logistics tail is a win-win scenario.”